NovoCure Ltd. NVCR
NASDAQ · United States · Health Technology
$15.92-0.03 (-0.19%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-23 | -0.13 | -0.33 | +60.8% | $183.58M | +6.5% | +13.4%$15.57→$17.65 |
| Q1 2026 | 2026-04-30 | -0.62 | -0.40 | -55.0% | — | — | +39.3%$11.93→$16.62 |
| Q4 2025 | 2026-02-26 | -0.22 | -0.41 | +46.3% | — | — | -8.8%$14.99→$13.67 |
| Q3 2025 | 2025-10-30 | -0.33 | -0.42 | +21.4% | — | — | -5.0%$13.48→$12.81 |
| Q2 2025 | 2025-07-24 | -0.36 | -0.39 | +7.7% | — | — | — |
| Q1 2025 | 2025-04-24 | -0.31 | -0.46 | +32.6% | — | — | — |
| Q2 2024 | 2024-07-25 | -0.31 | -0.40 | +22.5% | — | — | — |
| Q4 2023 | 2024-02-22 | -0.45 | -0.52 | +13.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.